Adverse Events During Upper Gastrointestinal Endoscopy

Adverse Events During Upper Gastrointestinal Endoscopy With and Without Sedation: a Multiple Center Report From Shanghai

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01979549

Acronym

AEDUGESSH

Enrollment

6000

Registered

2013-11-08

Start date

2013-12-31

Completion date

2014-12-31

Last updated

2014-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophagus Cancer, Gastric Cancer, Oesophagitis, Patients Need Upper Gastrointestinal Endoscopy, Peptic Ulcer

Keywords

Adverse events, Upper gastrointestinal endoscopy, Sedation

Brief summary

The primary objective is to investigate the adverse events during upper gastrointestinal endoscopy with and without sedation in Chinese population

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients will undergo upper gastrointestinal endoscopy * Age \> 18 years old * Signed informed consent form

Exclusion criteria

* Pregnant * Allergy to propofol or soybean or albumen

Design outcomes

Primary

Measure	Time frame	Description
Adverse events	Patients will be followed for the duration of hospital stay, an expected average of 2 hours	Investigate the adverse events according to the Adverse event reporting tool of the world SIVA International Sedation Task Force during upper gastrointestinal endoscopy with and without sedation.

Countries

China

Contacts

Primary ContactDiansan Su, Doctor

diansansu@yahoo.com0086-21-68383702

Backup ContactXiangrui Wang, Doctor

wangxr2010@yahoo.com0086-21-68383198

Outcome results